---
title: "Staidson BioPharm released its performance for the first three quarters, with a net loss attributable to the parent company of 30.6895 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263063882.md"
description: "According to the Zhitong Finance APP, Staidson BioPharm released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 181 million yuan, a year-on-year decrease of 30.82%. The net loss attributable to shareholders of the listed company was 30.6895 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 34.3569 million yuan. The basic loss per share was 0.06 yuan"
datetime: "2025-10-28T10:56:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263063882.md)
  - [en](https://longbridge.com/en/news/263063882.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263063882.md)
---

# Staidson BioPharm released its performance for the first three quarters, with a net loss attributable to the parent company of 30.6895 million yuan

According to the Zhitong Finance APP, Staidson BioPharm (300204.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 181 million yuan, a year-on-year decrease of 30.82%. The net loss attributable to shareholders of the listed company was 30.6895 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 34.3569 million yuan. The basic loss per share was 0.06 yuan

### Related Stocks

- [300204.CN](https://longbridge.com/en/quote/300204.CN.md)

## Related News & Research

- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [Mattel is Searching for the First Hot Wheels Tiniest Team Principal | MAT Stock News](https://longbridge.com/en/news/286957208.md)
- [God of War’s bold new spinoff stars Faye: will it work?](https://longbridge.com/en/news/286908907.md)
- [RUBBER-Japan futures extend gains on weaker yen, tight Thai supply](https://longbridge.com/en/news/286840226.md)
- [ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth](https://longbridge.com/en/news/286928593.md)